Early management of patients with acute heart failure: State of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of america acute heart failure working group

Journal of Cardiac Failure

Volumn 21, Issue 1, 2015, Pages 27-43

  Collins, Sean ^a   Storrow, Alan B ^a   Albert, Nancy M ^b   Butler, Javed ^c   Ezekowitz, Justin ^d   Felker, G Michael ^e   Fermann, Gregory J ^f   Fonarow, Gregg C ^g   Givertz, Michael M ^h   Hiestand, Brian ⁱ   Hollander, Judd E ^j   Lanfear, David E ^k   Levy, Phillip D ^l   Pang, Peter S ^m   Peacock, W Frank ⁿ   Sawyer, Douglas B ^a   Teerlink, John R ^o   Lenihan, Daniel J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UCLA MEDICAL CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ WAKE FOREST UNIVERSITY   (United States)

^j THOMAS JEFFERSON UNIVERSITY   (United States)

^k HENRY FORD HOSPITAL   (United States)

^l WAYNE STATE UNIVERSITY   (United States)

^m INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acute heart failure; early management; emergency medicine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALECTIN 3; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

ACUTE HEART FAILURE; BLOOD PRESSURE; CARDIAC PATIENT; CONSENSUS; EARLY INTERVENTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY PHYSICIAN; ENVIRONMENTAL FACTOR; HEALTH SERVICE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMPEDANCE CARDIOGRAPHY; IMPLANTABLE HEMODYNAMIC MONITOR; LENGTH OF STAY; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MEDICAL HISTORY; MEDICAL SOCIETY; OBSERVATION UNIT; PAROXYSMAL DYSPNEA; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PHENOTYPE; PHYSICAL EXAMINATION; POINT OF CARE TESTING; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK MANAGEMENT; SOCIAL ASPECT; THORAX RADIOGRAPHY; ACUTE DISEASE; DISEASE MANAGEMENT; EMERGENCY MEDICINE; FORECASTING; HEART FAILURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; TIME FACTOR; TRENDS; UNITED STATES;

ACUTE DISEASE; CONSENSUS; DISEASE MANAGEMENT; EMERGENCY MEDICINE; FORECASTING; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIETIES, MEDICAL; TIME FACTORS; UNITED STATES;

EID: 84919680189     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.07.003     Document Type: Article

References (161)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. A.B. Storrow, C.A. Jenkins, and W.H. Self The burden of acute heart failure on us emergency departments JACC Heart Fail 2 2014 269 277
3. A.S. Go, D. Mozaffarian, and V.L. Roger Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
4. P.A. Heidenreich, J.G. Trogdon, and O.A. Khavjou Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
5. W.F. Peacock, C. Emerman, M.R. Costanzo, D.B. Diercks, M. Lopatin, and G.C. Fonarow Early vasoactive drugs improve heart failure outcomes Congest Heart Fail 15 2009 256 264
6. A.S. Maisel, W.F. Peacock, and N. McMullin Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis J Am Coll Cardiol 52 2008 534 540
7. S. Brar, F.A. McAlister, E. Youngson, and B.H. Rowe Do outcomes for patients with heart failure vary by emergency department volume? Circ Heart Fail 6 2013 1147 1154
8. J.E. Rame, M.A. Sheffield, and D.L. Dries Outcomes after emergency department discharge with a primary diagnosis of heart failure Am Heart J 142 2001 714 719
9. A.J. Singer, R.H. Birkhahn, and D. Guss Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management Circ Heart Fail 2 2009 287 293
10. M. Hsieh, T.E. Auble, and D.M. Yealy Validation of the Acute Heart Failure Index Ann Emerg Med 51 2008 37 44
11. C. Mueller, K. Laule-Kilian, and C. Schindler Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea Arch Intern Med 166 2006 1081 1087
12. S. Collins, A.B. Storrow, J.D. Kirk, P.S. Pang, D.B. Diercks, and M. Gheorghiade Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department Ann Emerg Med 51 2008 45 57
13. C.S. Wang, J.M. FitzGerald, M. Schulzer, E. Mak, and N.T. Ayas Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 294 2005 1944 1956
14. G.C. Wong, and N.T. Ayas Clinical approaches to the diagnosis of acute heart failure Curr Opin Cardiol 22 2007 207 213
15. M.H. Drazner, J.E. Rame, L.W. Stevenson, and D.L. Dries Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure N Engl J Med 345 2001 574 581
16. M.H. Drazner, M.A. Hamilton, G. Fonarow, J. Creaser, C. Flavell, and L.W. Stevenson Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure J Heart Lung Transpl 18 1999 1126 1132
17. S.P. Collins, C.J. Lindsell, and W.F. Peacock The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea J Card Fail 12 2006 286 292
18. S.P. Collins, C.J. Lindsell, W.F. Peacock, V.D. Hedger, and A.B. Storrow The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure Am J Emerg Med 24 2006 25 32
19. S.P. Collins, C.J. Lindsell, A.B. Storrow, and W.T. Abraham Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure Ann Emerg Med 47 2006 13 18
20. G. Volpicelli, V. Caramello, L. Cardinale, A. Mussa, F. Bar, and M.F. Frascisco Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure Am J Emerg Med 26 2008 585 591
21. S. Chakko, D. Woska, and H. Martinez Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care Am J Med 90 1991 353 359
22. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
23. P.A. McCullough, J.E. Hollander, and R.M. Nowak Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department Acad Emerg Med 10 2003 198 204
24. K. Maeda, T. Tsutamoto, A. Wada, T. Hisanaga, and M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
25. J. Lindenfeld, N.M. Albert, and J.P. Boehmer HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
26. C.W. Yancy, M. Jessup, and B. Bozkurt 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
27. G. Karayannis, F. Triposkiadis, J. Skoularigis, P. Georgoulias, J. Butler, and G. Giamouzis The emerging role of galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers Curr Heart Fail Rep 10 2013 441 449
28. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R. van Kimmenade, and J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
29. A.S. Maisel, P. Clopton, and P. Krishnaswamy Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study Am Heart J 147 2004 1078 1084
30. S.M. Pasha, F.A. Klok, N. van der Bijl, A. de Roos, L.J. Kroft, and M.V. Huisman NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function Thromb Haemost 108 2012 367 372
31. A. Luchner, C. Hengstenberg, H. Lowel, G.A. Riegger, H. Schunkert, and S. Holmer Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP Hypertension 46 2005 118 123
32. L. Cavagna, R. Caporali, and C. Klersy Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis J Rheumatol 37 2010 2064 2070
33. A.J. Jorge, M.D. Freire, and M.L. Ribeiro Utility of B-type natriuretic peptide measurement in outpatients with heart failure with preserved ejection fraction Rev Port Cardiol 32 2013 647 652
34. T.J. Wang, M.G. Larson, and D. Levy Heritability and genetic linkage of plasma natriuretic peptide levels Circulation 108 2003 13 16
35. L.C. Costello-Boerrigter, G. Boerrigter, and S. Ameenuddin The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays Mayo Clinic Proc 86 2011 210 218
36. A. Maisel, C. Mueller, and K. Adams Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
37. P.A. McCullough, R.M. Nowak, and J. McCord B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study Circulation 106 2002 416 422
38. B.G. Carr, A.J. Dean, and W.W. Everett Intensivist bedside ultrasound (INBU) for volume assessment in the intensive care unit: a pilot study J Trauma 63 2007 495 500 discussion 500-2
39. B.J. Kimura, R. Dalugdugan, G.W. Gilcrease 3rd, J.N. Phan, B.K. Showalter, and T. Wolfson The effect of breathing manner on inferior vena caval diameter Eur J Echocardiogra 12 2011 120 123
40. A. Dean, and S. Stahmer Ultrasonography and emergency cardiac care J.M. Field, The textbook of emergency cardiovascular care and CPR 2009 Wolters Kluwer Philadelphia, PA 129 148
41. E. Agricola, T. Bove, and M. Oppizzi "Ultrasound comet-tail images": a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water Chest 127 2005 1690 1695
42. A.S. Liteplo, K.A. Marill, and T. Villen Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure Acad Emerg Med 16 2009 201 210
43. D.A. Lichtenstein, and G.A. Meziere Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol Chest 134 2008 117 125
44. G. Volpicelli, A. Mussa, and G. Garofalo Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome Am J Emerg Med 24 2006 689 696
45. D. Lichtenstein, I. Goldstein, E. Mourgeon, P. Cluzel, P. Grenier, and J.J. Rouby Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome Anesthesiology 100 2004 9 15
46. M. Maines, D. Catanzariti, C. Angheben, S. Valsecchi, J. Comisso, and G. Vergara Intrathoracic impedance and ultrasound lung comets in heart failure deterioration monitoring Pacing Clin Electrophysiol 34 2011 968 974
47. W. Mullens, L.P. Oliveira, T. Verga, B.L. Wilkoff, and W.H. Wilson Tang Insights from internet-based remote intrathoracic impedance monitoring as part of a heart failure disease management program Congest Heart Fail 16 2010 159 163
48. M. Shochat, G. Charach, and S. Meyler Internal thoracic impedance monitoring: a novel method for the preclinical detection of acute heart failure Cardiovasc Revasc Med 7 2006 41 45
49. M.M. Hirschl, H. Kittler, and C. Woisetschlager Simultaneous comparison of thoracic bioimpedance and arterial pulse waveform-derived cardiac output with thermodilution measurement Crit Care Med 28 2000 1798 1802
50. A. Piccoli, M. Codognotto, and V. Cianci Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA) J Card Fail 18 2012 226 232
51. K.H. Schlendorf, and S.D. Russell New diagnostic devices in heart failure Curr Opin Cardiol 25 2010 262 267
52. J.F. Neuenschwander, B.C. Hiestand, and W.F. Peacock A pilot study of implantable cardiac device interrogation by emergency department personnel Crit Pathw Cardiol 13 2014 6 8
53. R. Nowak, S. DiSomma, and P. Nanayakkara The noninvasive hemodynamic phenotyping of patients presenting to the emergency department with acute heart failure: prognostic and therapeutic implications 2014 Society for Academic Emergency Medicine Dallas
54. M.M. Givertz, J.R. Teerlink, and N.M. Albert Acute decompensated heart failure: update on new and emerging evidence and directions for future research J Card Fail 19 2013 371 389
55. G.M. Felker, K.L. Lee, and D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
56. J.R. Teerlink, G. Cotter, and B.A. Davison Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
57. B.A. Bart, S.R. Goldsmith, and K.L. Lee Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med 367 2012 2296 2304
58. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
59. A. Gray, S. Goodacre, D.E. Newby, M. Masson, F. Sampson, and J. Nicholl Noninvasive ventilation in acute cardiogenic pulmonary edema N Engl J Med 359 2008 142 151
60. C.M. O'Connor, R.C. Starling, and A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
61. A. Ramirez, and W.H. Abelmann Cardiac decompensation N Engl J Med 290 1974 499 501
62. M. Gheorghiade, and E. Braunwald A proposed model for initial assessment and management of acute heart failure syndromes JAMA 305 2011 1702 1703
63. W.F. Peacock, A. Chandra, and D. Char Clevidipine in acute heart failure: results of the A Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO) Am Heart J 167 2014 529 536
64. G. Cotter, G.M. Felker, K.F. Adams, O. Milo-Cotter, and C.M. O'Connor The pathophysiology of acute heart failure - is it all about fluid accumulation? Am Heart J 155 2008 9 18
65. G. Cotter, M. Metra, O. Milo-Cotter, H.C. Dittrich, and M. Gheorghiade Fluid overload in acute heart failure - re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 2008 165 169
66. P. Levy, S. Compton, and R. Welch Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis Ann Emerg Med 50 2007 144 152
67. G. Cotter, E. Metzkor, and E. Kaluski Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet 351 1998 389 393
68. M. Gheorghiade, W.T. Abraham, and N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
69. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
70. C. Fallick, P.A. Sobotka, and M.E. Dunlap Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation Circ Heart Fail 4 2011 669 675
71. S. Setoguchi, L.W. Stevenson, and S. Schneeweiss Repeated hospitalizations predict mortality in the community population with heart failure Am Heart J 154 2007 260 266
72. S.D. Solomon, J. Dobson, and S. Pocock Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
73. M.S. Cuffe, R.M. Califf, and K.F. Adams Jr. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
74. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331
75. M. Gheorghiade, W.A. Gattis, and C.M. O'Connor Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial JAMA 291 2004 1963 1971
76. A. Mebazaa, M.S. Nieminen, and M. Packer Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial JAMA 297 2007 1883 1891
77. M. Gheorghiade, M. Bohm, and S.J. Greene Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135
78. B.M. Massie, C.M. O'Connor, and M. Metra Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
79. J.J. McMurray, J.R. Teerlink, and G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019
80. A. Wakai, A. McCabe, and R. Kidney Nitrates for acute heart failure syndromes Cochrane Database Syst Rev 8 2013 CD005151
81. H.H. Chen, K.J. Anstrom, and M.M. Givertz Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial JAMA 310 2013 2533 2543
82. J.D. Schuur, and A.K. Venkatesh The growing role of emergency departments in hospital admissions N Engl J Med 367 2012 391 393
83. National Center for Health Statistics Health, United States, 2012: with a special feature on emergency care 2013 National Center for Health Statistics Hyattsville, Maryland
84. J.B. McCausland, M.S. Machi, and D.M. Yealy Emergency physicians' risk attitudes in acute decompensated heart failure patients Acad Emerg Med 17 2010 108 110
85. S.P. Collins, and A.B. Storrow Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making JACC Heart Fail 1 2013 273 280
86. J.A. Ezekowitz, J.A. Bakal, P. Kaul, C.M. Westerhout, and P.W. Armstrong Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure Eur J Heart Fail 10 2008 308 314
87. D.S. Lee, M.J. Schull, and D.A. Alter Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis Circ Heart Fail 3 2010 228 235
88. D.S. Lee, A. Stitt, and P.C. Austin Prediction of heart failure mortality in emergent care: a cohort study Ann Intern Med 156 2012 767 775
89. P.S. Pang, R. Jesse, S.P. Collins, and A. Maisel Patients with acute heart failure in the emergency department: do they all need to be admitted? J Card Fail 18 2012 900 903
90. N.L. Weintraub, S.P. Collins, and P.S. Pang Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association Circulation 122 2010 1975 1996
91. W.F. Peacock, T. De Marco, and G.C. Fonarow Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
92. S.P. Collins, C.J. Lindsell, and C.A. Jenkins Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies Am Heart J 164 2012 825 834
93. S.P. Collins, and A.B. Storrow Acute heart failure risk stratification: can we define low risk? Heart Fail Clin 5 2009 75 83 vii
94. J. Butler, S. Hanumanthu, D. Chomsky, and J.R. Wilson Frequency of low-risk hospital admissions for heart failure Am J Cardiol 81 1998 41 44
95. S.P. Collins, C.J. Lindsell, and A.J. Naftilan Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations Crit Pathw Cardiol 8 2009 99 103
96. S.P. Collins, W.F. Peacock, and C.J. Lindsell S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea Ann Emerg Med 53 2009 748 757
97. D.B. Diercks, W.F. Peacock, J.D. Kirk, and J.E. Weber ED patients with heart failure: identification of an observational unit-appropriate cohort Am J Emerg Med 24 2006 319 324
98. W.F. Peacock, G.C. Fonarow, and D.S. Ander Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee Crit Pathw Cardiol 7 2008 83 86
99. T.E. Auble, M. Hsieh, and W. Gardner A prediction rule to identify low-risk patients with heart failure Acad Emerg Med 12 2005 514 521
100. T.E. Auble, M. Hsieh, J.B. McCausland, and D.M. Yealy Comparison of four clinical prediction rules for estimating risk in heart failure Ann Emerg Med 50 2007 127 135 135e1-2
101. M. Metra, G. Cotter, and B.A. Davison Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes J Am Coll Cardiol 61 2013 196 206
102. Interqual actionable evidence-based criteria portfolio. 2013. Available at: www.mckeeson.com. Accessed April 3, 2014.
103. Indicia for utilization review. 2014. Available at www.careguidelines.com. Accessed April 3, 2014.
104. H. Wang, R.D. Robinson, and M. Coppola The accuracy of Interqual criteria in determining the need for observation versus hospitalization in emergency department patients with chronic heart failure Crit Pathw Cardiol 12 2013 192 196
105. A.F. Hernandez, M.A. Greiner, and G.C. Fonarow Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure JAMA 303 2010 1716 1722
106. D.S. Lee, T.A. Stukel, and P.C. Austin Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department Circulation 122 2010 1806 1814
107. A. Takeda, S.J. Taylor, R.S. Taylor, F. Khan, H. Krum, and M. Underwood Clinical service organisation for heart failure Cochrane Database Syst Rev 9 2012 CD002752
108. J.R. Wu, D.K. Moser, T.A. Lennie, and P.V. Burkhart Medication adherence in patients who have heart failure: a review of the literature Nurs Clin North Am 43 2008 133 153 vii-viii
109. M.H. van der Wal, and T. Jaarsma Adherence in heart failure in the elderly: problem and possible solutions Int J Cardiol 125 2008 203 208
110. A. Jovicic, J.M. Holroyd-Leduc, and S.E. Straus Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials BMC Cardiovasc Disord 6 2006 43
111. S. Barnason, L. Zimmerman, and L. Young An integrative review of interventions promoting self-care of patients with heart failure J Clin Nurs 21 2012 448 475
112. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
113. B. Riegel, and B. Carlson Facilitators and barriers to heart failure self-care Patient Educ Couns 46 2002 287 295
114. B. Riegel, D.K. Moser, and S.D. Anker State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association Circulation 120 2009 1141 1163
115. G.C. Fonarow, W.G. Stough, and W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry J Am Coll Cardiol 50 2007 768 777
116. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. de Marco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database J Am Coll Cardiol 47 2006 76 84
117. A.M. Sheehy, B. Graf, and S. Gangireddy Hospitalized but not admitted: characteristics of patients with "observation status" at an academic medical center JAMA Intern Med 173 2013 1991 1998
118. J.L. Wiler, M.A. Ross, and A.A. Ginde National study of emergency department observation services Acad Emerg Med 18 2011 959 965
119. N.N. Somekh, M. Rachko, G. Husk, P. Friedmann, and S.R. Bergmann Differences in diagnostic evaluation and clinical outcomes in the care of patients with chest pain based on admitting service: the benefits of a dedicated chest pain unit J Nucl Cardiol 15 2008 186 192
120. L.K. Leykum, V. Huerta, and E. Mortensen Implementation of a hospitalist-run observation unit and impact on length of stay (LOS): a brief report J Hosp Med 5 2010 E2 E5
121. B.P. Lucas, R. Kumapley, and B. Mba A hospitalist-run short-stay unit: features that predict length-of-stay and eventual admission to traditional inpatient services J Hosp Med 4 2009 276 284
122. J. Schrager, M. Wheatley, and V. Georgiopoulou Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients Acad Emerg Med 20 2013 554 561
123. A.B. Storrow, S.P. Collins, M.S. Lyons, L.E. Wagoner, W.B. Gibler, and C.J. Lindsell Emergency department observation of heart failure: preliminary analysis of safety and cost Congest Heart Fail 11 2005 68 72
124. W.F. Peacock, G.C. Fonarow, and D.S. Ander Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient - parts 1-6 Acute Card Care 11 2009 3 42
125. J.R. Teerlink, M. Metra, and G.M. Felker Relaxin for the Treatment of Patients With Acute Heart Failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 2009 1429 1439
126. J.A. Ezekowitz, A.F. Hernandez, and C.M. O'Connor Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow J Am Coll Cardiol 59 2012 1441 1448
127. P.S. Pang, M.A. Konstam, and H.B. Krasa Effects of tolvaptan on dyspnoea relief from the EVEREST trials Eur Heart J 30 2009 2233 2240
128. M. Metra, C.M. O'Connor, and B.A. Davison Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study Eur Heart J 32 2011 1519 1534
129. M. Metra, J.R. Teerlink, and G.M. Felker Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study Eur J Heart Fail 12 2010 1130 1139
130. P.S. Pang, J.G. Cleland, and J.R. Teerlink A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824
131. M. Redfield, J. Butler, and C.M. O'Connor Reliable evaluation of dyspnea in the ROSE AHF trial (RED ROSE) 2014 American College of Cardiology Washington
132. J. Afilalo, K.P. Alexander, and M.J. Mack Frailty assessment in the cardiovascular care of older adults J Am Coll Cardiol 63 2014 747 762
133. W.T. Abraham, P.B. Adamson, and R.C. Bourge Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
134. G.V. Sharma, P.A. Woods, and N. Lindsey Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial J Card Fail 17 2011 718 725
135. A. Maisel, J.E. Hollander, and D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333
136. P.A. McCullough, P. Duc, and T. Omland B-Type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly multinational study Am J Kidney Dis 41 2003 571 579
137. S.D. Sanford, K.L. Lichstein, H.H. Durrence, B.W. Riedel, D.J. Taylor, and A.J. Bush The influence of age, gender, ethnicity, and insomnia on Epworth sleepiness scores: a normative US population Sleep Med 7 2006 319 326
138. J. McCord, B.J. Mundy, and M.P. Hudson Relationship between obesity and B-type natriuretic peptide levels Arch Intern Med 164 2004 2247 2252
139. K. Goto, M. Arai, A. Watanabe, A. Hasegawa, A. Nakano, and M. Kurabayashi Utility of echocardiography versus BNP level for the prediction of pulmonary arterial pressure in patients with pulmonary arterial hypertension Int Heart J 51 2010 343 347
140. D. Logeart, L. Lecuyer, and G. Thabut Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism Intensive Care Med 33 2007 286 292
141. E.M. Hsich, M.V. Grau-Sepulveda, and A.F. Hernandez Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With the Guideline-Heart Failure registry Am Heart J 166 2013 1063 1071.e3
142. S.R. Krim, R.P. Vivo, and N.R. Krim Racial/ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from get with the guidelines-heart failure JACC Heart Fail 1 2013 345 352
143. S. Anwaruddin, D.M. Lloyd-Jones, and A. Baggish Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Am Coll Cardiol 47 2006 91 97
144. G. Hess, S. Runkel, D. Zdunek, and W.E. Hitzler N-Terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease Clin Lab 51 2005 167 172
145. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study Eur Heart J 27 2006 330 337
146. A. Bayes-Genis, D.M. Lloyd-Jones, and R.R. van Kimmenade Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea Arch Intern Med 167 2007 400 407
147. S.R. Das, M.H. Drazner, and D.L. Dries Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study Circulation 112 2005 2163 2168
148. T. Henzler, S. Roeger, and M. Meyer Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction Eur Respir J 39 2012 919 926
149. Z.F. Li, D.X. Zhou, Q.B. Wang, W.Z. Pan, L. Zhang, and J.B. Ge Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients Regul Pept 183C 2013 13 16
150. S.Y. Chi, E.Y. Kim, and H.J. Ban Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease Lung 190 2012 271 276
151. G.J. Mauritz, D. Rizopoulos, and H. Groepenhoff Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension Am J Cardiol 108 2011 1645 1650
152. M.N. Curiati, O.M. Silvestre, and L.J. Pires Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables Einstein (Sao Paulo) 11 2013 273 277
153. E.Y. Choi, H. Bahrami, and C.O. Wu N-Terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis Circ Heart Fail 5 2012 727 734
154. D.G. Krauser, A.A. Chen, R. Tung, S. Anwaruddin, A.L. Baggish, and J.L. Januzzi Jr. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy J Card Fail 12 2006 452 457
155. J. Lassus, E. Gayat, and C. Mueller Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study Int J Cardiol 168 2013 2186 2194
156. I.G. Stiell, C.M. Clement, and R.J. Brison A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events Acad Emerg Med 20 2013 17 26
157. P.N. Peterson, J.S. Rumsfeld, and L. Liang A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines program Circ Cardiovasc Qual Outcomes 3 2010 25 32
158. G.C. Fonarow, W.T. Abraham, and N.M. Albert Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF Arch Intern Med 168 2008 847 854
159. W.T. Abraham, G.C. Fonarow, and N.M. Albert Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 52 2008 347 356
160. L.E. Rohde, L. Goldraich, and C.A. Polanczyk A simple clinically based predictive rule for heart failure in-hospital mortality J Card Fail 12 2006 587 593
161. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, C.W. Yancy, and W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580